Effect of anti-anxiety therapy on the prognosis of patients with atrial fibrillation and anxiety: a 2 × 2 factorial randomized controlled trial - Report - MDSpire
Advertisement
Effect of anti-anxiety therapy on the prognosis of patients with atrial fibrillation and anxiety: a 2 × 2 factorial randomized controlled trial
Clinical Report: Impact of Anti-Anxiety Treatment on Outcomes in AF Patients
Overview
This study evaluates the efficacy of combined anti-anxiety therapy in patients with atrial fibrillation (AF) and anxiety. Results indicate improvements in quality of life and a reduction in major adverse cardiovascular events with integrated treatment approaches, as evidenced by statistical analysis.
Background
Atrial fibrillation (AF) is a prevalent arrhythmia that significantly impacts patients' quality of life (QoL). The co-occurrence of anxiety disorders with AF can exacerbate symptoms and worsen overall prognosis. Despite the importance of psychological management in AF care, there is limited evidence on the effectiveness of combined pharmacotherapy and psychological interventions.
Data Highlights
Group
QoL Improvement (SF-36)
Incidence of MACE
Combination (Drug + CBT)
P < 0.01
36.67%
Control
P > 0.05
70.00%
Key Findings
117 patients completed the follow-up at 6 months.
Improvements in Role-Physical, General Health, Vitality, and Social Functioning domains of the SF-36 in intervention groups (P < 0.01).
Psychological intervention and drug therapy showed significant main effects on QoL (P < 0.001 and P = 0.011, respectively).
The Combination group had a lower incidence of MACE compared to the Control group (P = 0.003).
Clinical Implications
The findings suggest that incorporating anti-anxiety pharmacotherapy and psychological therapy can enhance QoL and reduce cardiovascular risks in patients with AF and anxiety. This integrated approach may inform future treatment strategies in managing AF patients.
Conclusion
The study highlights the potential benefits of combined anti-anxiety treatments in improving outcomes for patients with AF and anxiety. Further research is warranted to explore the long-term effects of such interventions.
